Homebiotech

biotech

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

Rare oral cancer has distinct genetic profile

Jim Cornall - May 26, 2026

biotech

New tool decodes structures and motifs of RNA

Jim Cornall - May 26, 2026

biotech

Elite immune cells lead fight against multiple myeloma

Jim Cornall - May 25, 2026

biotech

Breakthru Medicine emerges from stealth to develop cancer drugs

Jim Cornall - February 5, 2026

biotech

FDA Rare Pediatric Disease designation for mucopolysaccharidosis Type II treatment

Jim Cornall - February 5, 2026

biotech

CIRM approves $100m plan to accelerate genetic therapies for patients with rare diseases

Jim Cornall - February 4, 2026

biotech

Researchers develop more reliable platform to test antibody medicines

Jim Cornall - February 4, 2026

biotech

Positive topline results from acne study

Jim Cornall - February 4, 2026

biotech

Sarbecovirus vaccine trial starts

Jim Cornall - February 3, 2026

biotech

Vetter Pharma to build new manufacturing site in Germany

Jim Cornall - February 3, 2026

biotech

New dementia treatment strategy proposed

Jim Cornall - February 3, 2026

1...242526...78 Page 25 of 78

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026 0

OSE Immunotherapeutics SA has announced the release of the abstract selected for an oral presentation at the upcoming ASCO 2026 annual meeting, unveiling topline...

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0

New tool decodes structures and motifs of RNA

biotech Jim Cornall - May 26, 2026 0

Elite immune cells lead fight against multiple myeloma

biotech Jim Cornall - May 25, 2026 0

National framework to strengthen UK advanced therapy clinical trials

biotech Jim Cornall - May 25, 2026 0